Yuyu Pharma, Inc.
000220 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000220004
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 제천시 바이오밸리1로 94, 제천시
- Website:
- https://www.yuyu.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 116.4 KB | ||
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 123.1 KB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 52.2 KB | ||
| 2025-07-15 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 67.0 KB | ||
| 2025-07-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 117.4 KB | ||
| 2025-05-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 67.6 KB | ||
| 2025-05-22 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 12.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-04-22 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 14.7 KB | ||
| 2025-04-15 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 24.0 KB | ||
| 2025-04-15 00:00 |
Capital/Financing Update
기타경영사항(자율공시)
|
Korean | 5.9 KB | ||
| 2025-04-11 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
|
Korean | 32.8 KB | ||
| 2025-03-27 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 14.0 KB | ||
| 2025-03-27 00:00 |
AGM Information
정기주주총회결과
|
Korean | 32.9 KB |
Automate Your Workflow. Get a real-time feed of all Yuyu Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Yuyu Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Yuyu Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America
CAMP
United States of America
CAMP
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden
CAMX
Sweden
CAMX
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America
CADL
United States of America
CADL
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel
CANF
Israel
CANF
Develops botanical medical solutions from cannabinoids & mushrooms for healthcare and wellness.
Israel
CNTC
Israel
CNTC
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany
27N0
Germany
27N0
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Sweden
CANTA
A European platform producing and distributing medical cannabis products to pharmacies.
Germany
HIGH
Germany
HIGH
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
United States of America
CAPR
United States of America
CAPR